Key Takeaways PTC unveiled Arena SCI, embedding AI-driven risk tools into its cloud-native PLM and QMS systems. SCI flags supply risks in real time and offers alternative parts, improving early-stage design decisions. PTC's acquisitions boost innovation but raise its debt-to-capital ratio to 0.29, above the 0.19 industry norm.PTC Inc. (PTC) recently introduced a transformative advancement for its Arena PLM (Product Lifecycle Management) and QMS (Quality Management System) solutions — the Arena Supply Chai ...

Image courtesy of PTC. Image courtesy of PTC. PTC will demonstrate Creo 12 at the International Paris Air Show from June 16 to 22, 2025, at Chalet #395. During this demonstration, visitors will discover how Hill Helicopters, the British manufacturer of sleek, light helicopters for private pilots, relies on PTC's generative design and simulation solutions. About PTC (NASDAQ: PTC) is a global software company that enables manufacturers and product companies to digitally transform how they design, manufacture, ...

DIGITAL INDUSTRIES SOFTWARE 在半导体元器件生命 周期管理中使用质量 管理方法 利用 PLM 平台上的原生 QMS 工具交付复杂的产品，同时简化价值链 siemens.com/software 半导体行业未来趋势 在半导体行业发展速度如此之快的情况下，调整和变革的必要性变得越来越明显。 可持续性 新兴技术 安全的数字化转型 全球化 以典范做法应对关键行业挑战 将质量相关信息左移，以避免在产品生命周 期后期出现成本高昂且耗时的质量相关问题。 周期性的芯片短缺和避免市场过度饱和的需 求促使制造商在发生中断时依赖更多合格的 零件和供应商。 支持从开发到生产的快速产品进步，以获得 创建新迭代的关键要点。 缩短上市时间 不稳定的芯片可用性 创新以保持竞争力 利用数字化解决方案连接孤岛 在不断变化的市场需求、急剧增加的竞争压力和资源限制的情况下，您需要持续改进核心流程。您需要在半导体生命周期管理中采用新 的策略来简化开发、提高生产力并保持质量。 适应复杂多变的市场绝非易事。依靠闭环质量策略来应对当今的半导体挑战非常有用。 在设计阶段管理质量 在设计过程的早期提高质量优先 级，以确保创新设计并满足 ...

BOSTON, April 2, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the acquisition of IncQuery Group. IncQuery Group offers application lifecycle management (ALM) and systems engineering development and consultancy services to global manufacturers and product companies. IncQuery Group helps simplify the product development process by connecting hardware and software engineering systems and enables better collaboration across development teams and more efficient management of product data. The acquisiti ...

Catalyst Pharmaceuticals (CPRX) Q4 2024 Earnings Call February 27, 2025 08:30 AM ET Company Participants Michael Kalb - Executive VP & CFORichard Daly - President & CEOJeff Del Carmen - Chief Commercial OfficerGary Ingenito - Chief Medical & Regulatory OfficerBenjamin Paluch - Equity Research Senior AssociateRohan Mathur - Equity Research AssociateFelix Ampomah - Senior Associate Conference Call Participants Charles Duncan - AnalystPavan Patel - AnalystAsim Rana - Equity AnalystJoseph Catanzaro - Director & ...